MaR1 inhibited the translocation of p65, a component of NF-κB, while promoting the activation of Nrf2, a key regulator of the antioxidant response that reduces oxidative stress and inflammation in this liver fibrosis model (Rodríguez et al., 2021). The gene discussed is NFKB1; the disease is Hepatic fibrosis.